Request Demo
Last update 08 May 2025
Valsartan/Cilnidipine
Last update 08 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Cilnidipine/valsartan, ATEDIO + [1] |
Target |
Action antagonists, blockers |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), VDCCs blockers(Voltage-gated calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (24 Mar 2014), |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC24H29N5O3 |
InChIKeyACWBQPMHZXGDFX-QFIPXVFZSA-N |
CAS Registry137862-53-4 |
View All Structures (2)
Related
5
Clinical Trials associated with Valsartan/CilnidipineJPRN-UMIN000019759
Effect of ATEDIO Combination Tab. on hypertension (Retrospective research study) - Hypotensive action (Retrospective research study)
NCT02343250
A Randomized, Open-label, Single Dosing, Two-way Crossover Clinical Trial to Compare the Safety/Tolerability and Pharmacokinetics of the Combination of Cilnidipine 10mg and Valsartan 160mg in Comparison to Each Component Coadministered in Healthy Male Volunteers
NCT02088008
A Randomized, Open-label, Single Dosing, Two-way Crossover Clinical Trial to Compare the Safety/Tolerability and Pharmacokinetics of the Combination of Cilnidipine 10mg and Valsartan 160mg in Comparison to Each Component Coadministered in Healthy Male Volunteers
100 Clinical Results associated with Valsartan/Cilnidipine
Login to view more data
100 Translational Medicine associated with Valsartan/Cilnidipine
Login to view more data
100 Patents (Medical) associated with Valsartan/Cilnidipine
Login to view more data
100 Deals associated with Valsartan/Cilnidipine
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Hypertension | Japan | 24 Mar 2014 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | 129 | scvvjljvfi(zswgxwwmlk) = rjsvqztlew xmjopvhphg (wnahaqkhrn ) View more | Negative | 01 Sep 2017 | |||
Valsartan/HCTZ (80/12.5 mg) | scvvjljvfi(zswgxwwmlk) = edcgvcnzrs xmjopvhphg (wnahaqkhrn ) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free